Home
Search

News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
Browse All
Olympian and Grand Slam Champion Venus Williams…
Seven-time Grand Slam singles champion, four-time Olympic gold medalist and entrepreneur Venus Williams will discuss her groundbreaking career, business success, and health journey in a conversation with Emmy-nominated sports reporter Erin Andrews…
Learn more
BIO Response to Second Global COVID-19 Summit
The White House today hosted world leaders and key public and private sector partners at the second Global COVID-19 Summit, a virtual event. Following the conversation, Dr. Michelle McMurry-Heath, President and CEO of the…
Learn more
BIO Statement on New PDUFA Package
The House Energy & Commerce Committee today unveiled a new package for the Prescription Drug User Fee Act (PDUFA). After the release, BIO’s Chief Science Officer, Cartier Esham, made the following remarks:  "For more than thirty years, the…
Learn more
Letters, Testimony, & Comments
Browse All
BIO Comments on FDA Guidance: Clinical…
On Monday, May 9th, BIO submitted comments in response to the FDA’s recent draft guidance on Clinical Pharmacology Considerations for Antibody-Drug Conjugates. In the comments submitted, BIO acknowledged the challenge FDA faces in creating a…
Learn more
BIO Leads Letter on Need for Biostimulants…
On behalf of the U.S. Biostimulant Coalition (USBC), the Biological Products Industry Alliance (BPIA), the American Seed Trade Association (ASTA), the Biotechnology Innovation Organization (BIO), and the Humic Products Trade Association, we are…
Learn more
BIO Letter to Senate Appropriations Committee on…
The Biotechnology Innovation Organization (BIO) is the largest biotechnology trade association, representing approximately 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United…
Learn more
Amicus Briefs
Browse All
BIO Files Amicus Brief in Petition for a Writ of…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
Learn more
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
Learn more
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
Learn more
Blog Posts
Browse all Blogs
Placeholder Image
Despite the COVID-19 Pandemic, the Bioscience Economy Remains Resilient
March 8, 2022
Throughout 2021, there was a great deal of advances in the biotechnology sector in the United States – thanks, in part, to state-led and regional economic development initiatives which have created jobs, advanced…
Covid Vaccine
2 Years In: Is the COVID-19 Pandemic Transitioning to Endemic?
March 11, 2022
Two years ago, the World Health Organization (WHO) declared COVID-19 a “pandemic.” We look back at key activities from BIO and the biopharmaceutical industry—and where we go from here.
Support Ukraine
Biotech Sector Unites to Aid Ukraine
March 8, 2022
Adding to the wide-scale human suffering across Ukraine, Russia’s unprovoked invasion of Ukraine is causing a major disruption to both medical as well as agricultural supply chains in the region and worldwide. As…